Search research articles
Contact Us
Filters
Showing results (721-730 of 732) with videos related to
Page
of 74
Sort By:
Nature
|
April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
Jean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
British Journal of Cancer
|
July 7, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty, et al.
Physical Review Letters
|
April 6, 2001
Measurement of the charged pion electromagnetic form factor
J Volmer, D Abbott, H Anklin, et al.
Nature Communications
|
May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial
Jean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Physical Review Letters
|
August 11, 2001
Measurement of the electric form factor of the neutron through d-->(e-->,e(')n)p at Q2 = 0.5 (GeV/c)(2)
H Zhu, A Ahmidouch, H Anklin, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
C E Geyer, J E Garber, R D Gelber, et al.
Physical Review Letters
|
May 27, 2014
Separated response function ratios in exclusive, forward π(±) electroproduction
G M Huber, H P Blok, C Butuceanu, et al.
Science (New York, N.Y.)
|
April 27, 2023
Evolutionary constraint and innovation across hundreds of placental mammals
Matthew J Christmas, Irene M Kaplow, Diane P Genereux, et al.
Page
of 74
Search research articles
Search
Showing results (721-730 of 732) with videos related to
Sort By:
Page
of 74
Nature
|
April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
Jean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
British Journal of Cancer
|
July 7, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty, et al.
Physical Review Letters
|
April 6, 2001
Measurement of the charged pion electromagnetic form factor
J Volmer, D Abbott, H Anklin, et al.
Nature Communications
|
May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial
Jean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Physical Review Letters
|
August 11, 2001
Measurement of the electric form factor of the neutron through d-->(e-->,e(')n)p at Q2 = 0.5 (GeV/c)(2)
H Zhu, A Ahmidouch, H Anklin, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
C E Geyer, J E Garber, R D Gelber, et al.
Physical Review Letters
|
May 27, 2014
Separated response function ratios in exclusive, forward π(±) electroproduction
G M Huber, H P Blok, C Butuceanu, et al.
Science (New York, N.Y.)
|
April 27, 2023
Evolutionary constraint and innovation across hundreds of placental mammals
Matthew J Christmas, Irene M Kaplow, Diane P Genereux, et al.
Page
of 74